A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

NCT03397862 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Irritation
Sensitization

Interventions

DRUG: Donepezil TDS
DRUG: Vehicle TDS

Sponsor

Corium, Inc.